Optimal chemotherapy for advanced breast cancer: a cost-utility comparison ; partial proceedings of a satellite symposium to the 4th European Winter Oncology Congress, Méribel, France, 22 January 1995
Gespeichert in:
| Format: | Tagungsbericht Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Auckland [u.a.]
Adis Internat.
1996
|
| Schriftenreihe: | PharmacoEconomics
9, Suppl. 2 |
| Schlagworte: | |
| Beschreibung: | Einzelaufnahme eines Zeitschr.-Suppl. |
| Beschreibung: | 36 S. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV011540752 | ||
| 003 | DE-604 | ||
| 005 | 20041007 | ||
| 007 | t| | ||
| 008 | 970919s1996 xx |||| 10||| eng d | ||
| 035 | |a (OCoLC)37465954 | ||
| 035 | |a (DE-599)BVBBV011540752 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-19 | ||
| 245 | 1 | 0 | |a Optimal chemotherapy for advanced breast cancer |b a cost-utility comparison ; partial proceedings of a satellite symposium to the 4th European Winter Oncology Congress, Méribel, France, 22 January 1995 |c guest ed. Bruce E. Hillner ... |
| 264 | 1 | |a Auckland [u.a.] |b Adis Internat. |c 1996 | |
| 300 | |a 36 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a PharmacoEconomics |v 9, Suppl. 2 | |
| 500 | |a Einzelaufnahme eines Zeitschr.-Suppl. | ||
| 650 | 4 | |a Breast Neoplasms |x drug therapy |v Congresses | |
| 650 | 4 | |a Breast |x Cancer |x Chemotherapy |v Congresses | |
| 650 | 4 | |a Outcome and Process Assessment (Health Care) |v Congresses | |
| 650 | 4 | |a Outcome assessment (Medical care) | |
| 650 | 4 | |a Treatment Outcome |v Congresses | |
| 650 | 0 | 7 | |a Cytostatikum |0 (DE-588)4068347-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Brustkrebs |0 (DE-588)4008528-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Kosten-Nutzen-Analyse |0 (DE-588)4032589-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Gesundheitsökonomie |0 (DE-588)4130935-2 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Brustkrebs |0 (DE-588)4008528-4 |D s |
| 689 | 0 | 1 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
| 689 | 0 | 2 | |a Gesundheitsökonomie |0 (DE-588)4130935-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Brustkrebs |0 (DE-588)4008528-4 |D s |
| 689 | 1 | 1 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
| 689 | 1 | 2 | |a Kosten-Nutzen-Analyse |0 (DE-588)4032589-1 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Hillner, Bruce E. |e Sonstige |4 oth | |
| 711 | 2 | |a European Winter Oncology Congress |n 4 |d 1995 |c Méribel |j Sonstige |0 (DE-588)5200029-1 |4 oth | |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-007768666 | |
Datensatz im Suchindex
| _version_ | 1823607495835254784 |
|---|---|
| adam_text | |
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV011540752 |
| ctrlnum | (OCoLC)37465954 (DE-599)BVBBV011540752 |
| format | Conference Proceeding Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 cb4500</leader><controlfield tag="001">BV011540752</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20041007</controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">970919s1996 xx |||| 10||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)37465954</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV011540752</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Optimal chemotherapy for advanced breast cancer</subfield><subfield code="b">a cost-utility comparison ; partial proceedings of a satellite symposium to the 4th European Winter Oncology Congress, Méribel, France, 22 January 1995</subfield><subfield code="c">guest ed. Bruce E. Hillner ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Auckland [u.a.]</subfield><subfield code="b">Adis Internat.</subfield><subfield code="c">1996</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">36 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">PharmacoEconomics</subfield><subfield code="v">9, Suppl. 2</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Einzelaufnahme eines Zeitschr.-Suppl.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Breast Neoplasms</subfield><subfield code="x">drug therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Breast</subfield><subfield code="x">Cancer</subfield><subfield code="x">Chemotherapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Outcome and Process Assessment (Health Care)</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Outcome assessment (Medical care)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Treatment Outcome</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kosten-Nutzen-Analyse</subfield><subfield code="0">(DE-588)4032589-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gesundheitsökonomie</subfield><subfield code="0">(DE-588)4130935-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Gesundheitsökonomie</subfield><subfield code="0">(DE-588)4130935-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Kosten-Nutzen-Analyse</subfield><subfield code="0">(DE-588)4032589-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hillner, Bruce E.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="711" ind1="2" ind2=" "><subfield code="a">European Winter Oncology Congress</subfield><subfield code="n">4</subfield><subfield code="d">1995</subfield><subfield code="c">Méribel</subfield><subfield code="j">Sonstige</subfield><subfield code="0">(DE-588)5200029-1</subfield><subfield code="4">oth</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007768666</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Aufsatzsammlung Konferenzschrift |
| id | DE-604.BV011540752 |
| illustrated | Not Illustrated |
| indexdate | 2025-02-09T19:00:31Z |
| institution | BVB |
| institution_GND | (DE-588)5200029-1 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-007768666 |
| oclc_num | 37465954 |
| open_access_boolean | |
| owner | DE-12 DE-19 DE-BY-UBM |
| owner_facet | DE-12 DE-19 DE-BY-UBM |
| physical | 36 S. |
| publishDate | 1996 |
| publishDateSearch | 1996 |
| publishDateSort | 1996 |
| publisher | Adis Internat. |
| record_format | marc |
| series2 | PharmacoEconomics |
| spelling | Optimal chemotherapy for advanced breast cancer a cost-utility comparison ; partial proceedings of a satellite symposium to the 4th European Winter Oncology Congress, Méribel, France, 22 January 1995 guest ed. Bruce E. Hillner ... Auckland [u.a.] Adis Internat. 1996 36 S. txt rdacontent n rdamedia nc rdacarrier PharmacoEconomics 9, Suppl. 2 Einzelaufnahme eines Zeitschr.-Suppl. Breast Neoplasms drug therapy Congresses Breast Cancer Chemotherapy Congresses Outcome and Process Assessment (Health Care) Congresses Outcome assessment (Medical care) Treatment Outcome Congresses Cytostatikum (DE-588)4068347-3 gnd rswk-swf Pharmakotherapie (DE-588)4076066-2 gnd rswk-swf Brustkrebs (DE-588)4008528-4 gnd rswk-swf Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd rswk-swf Gesundheitsökonomie (DE-588)4130935-2 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content (DE-588)1071861417 Konferenzschrift gnd-content Brustkrebs (DE-588)4008528-4 s Pharmakotherapie (DE-588)4076066-2 s Gesundheitsökonomie (DE-588)4130935-2 s DE-604 Cytostatikum (DE-588)4068347-3 s Kosten-Nutzen-Analyse (DE-588)4032589-1 s Hillner, Bruce E. Sonstige oth European Winter Oncology Congress 4 1995 Méribel Sonstige (DE-588)5200029-1 oth |
| spellingShingle | Optimal chemotherapy for advanced breast cancer a cost-utility comparison ; partial proceedings of a satellite symposium to the 4th European Winter Oncology Congress, Méribel, France, 22 January 1995 Breast Neoplasms drug therapy Congresses Breast Cancer Chemotherapy Congresses Outcome and Process Assessment (Health Care) Congresses Outcome assessment (Medical care) Treatment Outcome Congresses Cytostatikum (DE-588)4068347-3 gnd Pharmakotherapie (DE-588)4076066-2 gnd Brustkrebs (DE-588)4008528-4 gnd Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd Gesundheitsökonomie (DE-588)4130935-2 gnd |
| subject_GND | (DE-588)4068347-3 (DE-588)4076066-2 (DE-588)4008528-4 (DE-588)4032589-1 (DE-588)4130935-2 (DE-588)4143413-4 (DE-588)1071861417 |
| title | Optimal chemotherapy for advanced breast cancer a cost-utility comparison ; partial proceedings of a satellite symposium to the 4th European Winter Oncology Congress, Méribel, France, 22 January 1995 |
| title_auth | Optimal chemotherapy for advanced breast cancer a cost-utility comparison ; partial proceedings of a satellite symposium to the 4th European Winter Oncology Congress, Méribel, France, 22 January 1995 |
| title_exact_search | Optimal chemotherapy for advanced breast cancer a cost-utility comparison ; partial proceedings of a satellite symposium to the 4th European Winter Oncology Congress, Méribel, France, 22 January 1995 |
| title_full | Optimal chemotherapy for advanced breast cancer a cost-utility comparison ; partial proceedings of a satellite symposium to the 4th European Winter Oncology Congress, Méribel, France, 22 January 1995 guest ed. Bruce E. Hillner ... |
| title_fullStr | Optimal chemotherapy for advanced breast cancer a cost-utility comparison ; partial proceedings of a satellite symposium to the 4th European Winter Oncology Congress, Méribel, France, 22 January 1995 guest ed. Bruce E. Hillner ... |
| title_full_unstemmed | Optimal chemotherapy for advanced breast cancer a cost-utility comparison ; partial proceedings of a satellite symposium to the 4th European Winter Oncology Congress, Méribel, France, 22 January 1995 guest ed. Bruce E. Hillner ... |
| title_short | Optimal chemotherapy for advanced breast cancer |
| title_sort | optimal chemotherapy for advanced breast cancer a cost utility comparison partial proceedings of a satellite symposium to the 4th european winter oncology congress meribel france 22 january 1995 |
| title_sub | a cost-utility comparison ; partial proceedings of a satellite symposium to the 4th European Winter Oncology Congress, Méribel, France, 22 January 1995 |
| topic | Breast Neoplasms drug therapy Congresses Breast Cancer Chemotherapy Congresses Outcome and Process Assessment (Health Care) Congresses Outcome assessment (Medical care) Treatment Outcome Congresses Cytostatikum (DE-588)4068347-3 gnd Pharmakotherapie (DE-588)4076066-2 gnd Brustkrebs (DE-588)4008528-4 gnd Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd Gesundheitsökonomie (DE-588)4130935-2 gnd |
| topic_facet | Breast Neoplasms drug therapy Congresses Breast Cancer Chemotherapy Congresses Outcome and Process Assessment (Health Care) Congresses Outcome assessment (Medical care) Treatment Outcome Congresses Cytostatikum Pharmakotherapie Brustkrebs Kosten-Nutzen-Analyse Gesundheitsökonomie Aufsatzsammlung Konferenzschrift |
| work_keys_str_mv | AT hillnerbrucee optimalchemotherapyforadvancedbreastcanceracostutilitycomparisonpartialproceedingsofasatellitesymposiumtothe4theuropeanwinteroncologycongressmeribelfrance22january1995 AT europeanwinteroncologycongressmeribel optimalchemotherapyforadvancedbreastcanceracostutilitycomparisonpartialproceedingsofasatellitesymposiumtothe4theuropeanwinteroncologycongressmeribelfrance22january1995 |